Quantum BioPharma's Unbuzzd Shines in Men's Fitness Trial Review
October 20, 2026 — Quantum BioPharma's Unbuzzd alcohol recovery formula shows promising trial results in Men's Fitness. Learn about the study, limitations, and market potential.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Scinai Immunotherapeutics Reports 300% Surge in CDMO Orders
October 20, 2026 — Scinai Immunotherapeutics (SCNI) reports CDMO orders up 300% to $8.1M, extended runway to late 2027, and $5.3M in net proceeds from recent financings.
HHS Awards $1.5M to Boost Agentic AI and Lab Interoperability
October 20, 2026 — HHS grants $1.5M to two healthcare research groups to advance agentic AI and laboratory interoperability, aiming to improve health information exchange and accelerate AI adoption.
Bangladesh's Measles Outbreak Tops 200,000 Suspected Cases
October 20, 2026 — Bangladesh reports over 200,000 suspected measles cases and 22,000 confirmed, highlighting falling vaccination rates and warning other nations like the U.S. about outbreak risks.
NanoViricides' NV-387 Shows Safety in Juvenile Mice, Paving Way for Pediatric Trials
October 20, 2026 — NanoViricides' NV-387 shows positive safety in juvenile mice, supporting pediatric trials for Ebola, Mpox, and measles. The broad-spectrum antiviral advances.
ECGI Holdings Featured in AINewsWire Editorial on AI-Powered Healthcare
October 20, 2026 — ECGI Holdings (OTC: ECGI) gains visibility through AINewsWire editorial on AI-powered healthcare, highlighting its Avanta Group acquisition and entry into coordinated care.
VERAXA Expands Human-Relevant Testing to Advance Cancer Pipeline
October 20, 2026 — VERAXA Biotech (NASDAQ: VRXA) is expanding FDA-aligned New Approach Methodologies across its cancer pipeline, cutting animal use while advancing BiTAC T-cell engagers.
Oncotelic's Saran Saund to Keynote Drug Discovery Summit on AI
October 20, 2026 — Oncotelic Therapeutics' Saran Saund to keynote 22nd Drug Discovery Strategic Summit, discussing AI-enabled drug discovery and the PDAOAI platform indexing 29 million abstracts.
DCS Releases Fire Watch Guide for Worksite Safety
October 20, 2026 — Diversified Compliance Solutions releases guide on fire watch protocols, OSHA/NFPA compliance, and safety responsibilities for industrial worksites.
ADAP Advocacy Launches Grassroots Hub as Waiting Lists Emerge
October 20, 2026 — ADAP Advocacy launches interactive grassroots hub to combat HIV drug assistance waiting lists in Iowa and Utah, affecting over 1,000 clients. Advocates mobilize.
Dr. Mona Mofid Named San Diego Top Doctor for 9th Time
October 20, 2026 — Dr. Mona Mofid, board-certified dermatologist, earns San Diego Top Doctor 2026 honors for the ninth time, plus awards for patient satisfaction and team excellence.
NYC Hospital Held Liable in Wrongful Death of 23-Year-Old Woman
October 20, 2026 — Jacob D. Fuchsberg Law Firm wins verdict against NYC Health + Hospitals for a 23-year-old woman's death due to delayed DKA treatment at Woodhull Hospital.
KJT Law Group Wins $650K for Family Injured by Speeding Delivery Driver
October 20, 2026 — KJT Law Group secured a $650,000 settlement for a man and two minors injured in a T-bone crash with a speeding delivery driver. Learn how they won.
Pentixapharm Builds Global Evidence for Pentixafor PET in Primary Aldosteronism
October 19, 2026 — Pentixapharm reports new EANM 2026 data supporting Pentixafor PET for non-invasive subtyping of primary aldosteronism, reinforcing the Phase 3 PANDA study.
Nanox AI Signs Distribution Deal to Bring HealthOST to Italy
October 19, 2026 — Nanox AI partners with Technologic s.r.l. to distribute HealthOST, its AI-powered bone health solution, in Italy, expanding preventive care in the Italian market.
Quantum BioPharma's Unbuzzd Shows Promise in Alcohol Recovery Study
October 19, 2026 — Quantum BioPharma's Unbuzzd shows promise in a clinical trial for alcohol recovery, with Men's Fitness reporting significant reductions in blood alcohol and improved alertness. Learn more.
New Brain Tumor Vaccine Shows Long-Term Survival Promise
October 19, 2026 — A new therapeutic vaccine extends survival in aggressive brain tumors, with two-thirds of patients alive after eight years. CNS Pharmaceuticals and others advance brain cancer treatments.
ECGI Holdings Acquires Avanta Group to Advance AI-Powered Proactive Care
October 19, 2026 — ECGI Holdings acquires Avanta Group to advance AI-powered proactive care in Medicare Advantage. Learn how this shift impacts healthcare spending and industry leaders.
Cotecna Acquires Energon Labs to Boost Pharma Testing in India
October 19, 2026 — Cotecna acquires Energon Labs, a USFDA-inspected lab in Hyderabad, expanding pharmaceutical testing capabilities and strengthening its Life Sciences platform in India.
ECGI Holdings Featured in AINewsWire Editorial on AI-Driven Preventive Care
October 19, 2026 — ECGI Holdings (OTC: ECGI) featured in AINewsWire editorial on AI-driven preventive healthcare and its Avanta Group acquisition, targeting the $5.3T U.S. healthcare market.